---
title: Crystec Limited (CrystecPharma) vs Sinopep-Allsino Biopharmaceutical Co., Ltd.
slug_a: crystecpharma
slug_b: sinopep
site: cdmo
review_signal_gate: closed
canonical_path: /compare/crystecpharma/sinopep
---

# Crystec Limited (CrystecPharma) vs Sinopep-Allsino Biopharmaceutical Co., Ltd.

Side-by-side profile data from each company listing on this directory.

## Crystec Limited (CrystecPharma)

- Profile: [/companies/crystecpharma](/companies/crystecpharma)

Crystec Limited (CrystecPharma) — Crystec Limited (CrystecPharma) is a pharmaceutical technology company that offers its mSAS® supercritical-fluid particle engineering platform to improve the bioavailability, stability and delivery of small and large molecule therapeutics. Its work is aimed at clients developing new and existing medicines.

Services: 4. Modalities: 5. Indications: 1. Locations: 4. Certifications: 0. The strongest documented coverage currently appears in modalities (5).

### Services

- Solid-State Chemistry & Polymorph Screening
- Inhalation & Nasal Dosage Manufacturing
- Process Development
- Formulation Development

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Oligonucleotide
- Peptide

### Development capabilities

- Formulation development

### Manufacturing capabilities

- Data not yet provided.

## Sinopep-Allsino Biopharmaceutical Co., Ltd.

- Profile: [/companies/sinopep](/companies/sinopep)

Sinopep-Allsino Biopharmaceutical Co., Ltd. — GMP peptide and oligonucleotide CDMO offering custom synthesis, NCE development, CMC manufacturing, and finished dosage form formulation services for therapeutic programs.

Services: 6. Modalities: 2. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (6).

### Services

- Oligonucleotide Manufacturing
- Peptide Manufacturing
- Process Development
- Formulation Development
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Oligonucleotide
- Peptide

### Development capabilities

- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)